A viable allogeneic human skin equivalent (HSE) containing both epider
mal and dermal components has been developed to accelerate cutaneous w
ound healing. A multicenter, prospective, randomized study of 293 pati
ents with leg ulcers secondary to venous insufficiency demonstrated si
gnificantly greater and faster complete healing rates by the HSE compa
red with conventional treatment (P=.021 and P=.003, respectively). We
present three cases from this trial. These cases suggest that HSE prom
otes healing through as yet unidentified mechanism(s). In some instanc
es, HSE seems to induce healing-by secondary intention, while in other
s the graft seems to ''take'' with no apparent clinical rejection.